Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-04-02-2010
Volume34
Issue 4

Pharmaceutical Technology, April 2010 Issue (PDF)

Spending More Or Less, And On What?

External Link - article-819779.pdf

Articles in this issue
i1-664324-1408640326267.jpg
Inside USP: USP Reaches 2500 Reference Standards
Tracking Solid-Dosage Equipment
Tracking Solid-Dosage Equipment
i1-664332-1408640290028.jpg
Inside EDQM: The Role of the Pharmacopeia in a Globalized World
Spherical Crystallization for Lean Solid-Dosage Manufacturing (Part II)
Spherical Crystallization for Lean Solid-Dosage Manufacturing (Part II)
More Questions than Answers
i1-664334-1408640284329.jpg
Stay Current at INTERPHEX
Unconventional Communication
i4-664328-1408640301552.jpg
The Effect of Overencapsulation on Disintegration and Dissolution
i3_t-664329-1408640297848.jpg
In the Spotlight April 2010
Report from Asia
Report from Asia
Reduced-Method Robustness Testing of Analytical Methods Driven by a Risk-Based Approach
i28-664326-1408640307865.jpg
Industry Pipeline
i1-664320-1408640343611.jpg
Delivering on the Promise of Biotechnology
Spending More or Less, and on What?
Spending More or Less, and on What?
The Evolution of Single-Use Technologies in Aseptic Processing
The Evolution of Single-Use Technologies in Aseptic Processing

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 5th 2025

Lilly’s Kisunla Demonstrates Growing Benefit in Treating Early Alzheimer’s Disease

Feliza Mirasol
Findings from a Phase III study highlight the demonstrated action of donanemab-azbt (brand name Kisunla) in slowing the decline of patients exhibiting early symptomatic Alzheimer’s disease.
Drug Solutions Podcast: Sustainable Solutions for Biopharma
August 5th 2025

Drug Solutions Podcast: Sustainable Solutions for Biopharma

Patrick Lavery
In this podcast episode, we discuss sustainable approaches to such equipment and materials as medical propellants, flow sensor technology, and walk-in chambers, plus the critical role of women in elevating and accelerating development in these areas.
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 5th 2025

Roche Reveals New Data from Alzheimer’s Disease Research at AAIC 2025

Feliza Mirasol
The company presented new data from its Alzheimer’s disease research efforts across its diagnostics and pharmaceutical portfolios at this year’s AAIC.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
August 5th 2025

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Site Logo
August 5th 2025

Transforming the pharmaceutical value chain for emerging biotechs and large pharmas

Patheon
Integrating development, manufacturing, and research processes enhances e¬ciency and accelerates time to market
Site Logo
August 5th 2025

Value reimagined: Unlocking ROI and efficiency in drug development

Patheon